IP Verse

Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis

PatentPatent Analysis

EP3041476

ADARE I
Application Number
EP14842811A
Filing Date
Sep 5, 2014
Status
Patent Maintained As Amended
Dec 23, 2022
Grant Date
Jan 25, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3403654B1
EP2482822B1

Bibliography

The patent EP3041476B2 was granted to Adare I on Jan 25, 2023 following the initial filing on Sep 5, 2014 under the application number EP14842811A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DR FALK PHARMAJul 22, 2020ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents